Research
Hormonal
Younger participants (under 51 years) experience significantly greater weight loss from the same intervention compared to older participants (over 51 years).
If you are over 50, the standard 1500-1800 calorie/30-min aerobic plan may not yield significant weight loss on its own. You may need to adjust expectations, consult your provider for age-specific strategies (like adding strength training), and focus on health markers beyond just the scale.
ModerateQualifiesLOW confidence
Age and weight loss was assessed in groups (<31, 31-50, >51) with significant weight loss seen in younger participants (p = 0.03, t = 2.93) and (p = 0.03, t = 2.11). Weight loss for those over 51 years was not significant (p = 0.12, t = 1.24).
Why this rating
Based on the same small, single-group study (n=38), limiting statistical power for subgroup analysis.
Source
An Interventional Approach to Obesity in an Ambulatory Care Setting
Nadine M. Aktan · Community Medicine & Public Health Care · 2016
DOI 10.24966/cmph-1978/100020
clinical_trial · n=38
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →